Greetings
Dear Colleagues
In this opportunity, I would like to explain our company's history, our present activities and our future targets in brief.
Our company was founded in 1950 by Misao Tomiyama in Nagano, 200km north from Tokyo, and at the beginning, our products were mainly extracts of traditional medicine.
Our epoch making product was Marzulene-S for gastric ulcer and gastritis which once recorded the third top selling product in Japanese prescription drug market.
Encouraged by success of Marzulene-S, we shifted our efforts to new drug development especially to GI tract field and the fruit of our efforts was new drug Azuloxa granules, the successors of Marzulene-S. Beyond GI tract, our developing efforts are expanded to cardiovascular disease, diabetes, dislipidemia and so on now. One of such typical substance is pratosartan.
Our policies for development of these chemical entities are to promote co-development and license-out, positively. Experienced partners strongly expect to develop our candidates.
Please visit another page of this site to find our under development compounds and also our plentiful patents.
We, KOTOBUKI, continue to put our best endeavors to fulfill the so-called un-met medical needs in various field and wish to contribute much more to everyone’s better health and life.
Sincerely yours
Akira Tomiyama Ph.D.
President
Head Quarters
Factory
Tokyo office
Osaka office
